MSI2 and neoplasm: While we have used the Msi2 reporters to establish a baseline for normal haematopoietic stem and progenitor cells, they could be useful in multiple contexts: for example, we have used this model to track heterogeneity within aggressive solid cancers, and find it enables successful identification of tumour propagating cells, and therapy resistance in pancreatic cancer18.